Jorey Chernett Increases Stake in Neuronetics, Inc. to 15.17% via Open Market Purchases

Jorey Chernett filed Amendment No. 2 to Schedule 13D on May 27, 2026, reporting an increased stake in Neuronetics, Inc. (STIM). As of May 19, 2026, Mr. Chernett beneficially owns 10,553,988 shares of common stock, representing approximately 15.17% of the company based on 69,587,840 shares outstanding. This is an increase from his previously reported position of 9,778,718 shares (14.12%). The acquisitions leading to this amendment involved several open-market purchases between April 20 and May 19, 2026, totaling 775,270 additional shares. Notable transactions included the purchase of 475,000 shares at a weighted average price of $1.34 on May 12 and 100,000 shares at $1.17 on May 19. All shares were purchased using personal funds for an aggregate purchase price of approximately $20,619,936. Mr. Chernett maintains sole voting and dispositive power over all 10,553,988 shares. The filing continues to reflect his significant investment position in the issuer.